Alpha-fetoprotein (AFP) and proteins induced by vitamin K absence II (PIVKA-II) are the primary serum biomarkers used for HCC surveillance at present; however, the sensitivity (62–65%) and specificity (approximately 87%) of AFP are often insufficient for the detection of early-stage HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.